Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Scotlandi

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Oncogene|February 1, 2011
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signalingC Garofalo, M C Manara, G Nicoletti, et al.
Oncogene|January 11, 2011
Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcomaJ Ban, G Jug, P Mestdagh, et al.
Acta Oncologica (Stockholm, Sweden)|March 14, 2018
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patientsE Palmerini, R L Jones, E Setola, et al.
BMC Cancer|September 26, 2023
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experienceElisabetta Setola, S Benini, A Righi, et al.
Oncogene|August 9, 2011
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcomaC Mackintosh, J L Ordóñez, D J García-Domínguez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2016
Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcomeS Ruiz-Pinto, G Pita, A Patiño-García, et al.
Critical Reviews in Oncology/Hematology|April 23, 2022
SELNET clinical practice guidelines for bone sarcomaJ Y Blay, E Palmerini, J Bollard, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Oncogene|February 1, 2011
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signalingC Garofalo, M C Manara, G Nicoletti, et al.
Oncogene|January 11, 2011
Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcomaJ Ban, G Jug, P Mestdagh, et al.
Acta Oncologica (Stockholm, Sweden)|March 14, 2018
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patientsE Palmerini, R L Jones, E Setola, et al.
BMC Cancer|September 26, 2023
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experienceElisabetta Setola, S Benini, A Righi, et al.
Oncogene|August 9, 2011
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcomaC Mackintosh, J L Ordóñez, D J García-Domínguez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2016
Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcomeS Ruiz-Pinto, G Pita, A Patiño-García, et al.
Critical Reviews in Oncology/Hematology|April 23, 2022
SELNET clinical practice guidelines for bone sarcomaJ Y Blay, E Palmerini, J Bollard, et al.
Pageof 9